Skip to content
- Zebrafish Xenografts Unveil Sensitivity to Olaparib beyond BRCA Status.
- Varanda AB, Martins-Logrado A, Ferreira MG, Fior R.
- Cancers (Basel). 2020 Jul 2;12(7):E1769. doi: 10.3390/cancers12071769.
- Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives.
- Cocco S, Piezzo M, Calabrese A, Cianniello D, Caputo R, Lauro VD, Fusco G, Gioia GD, Licenziato M, Laurentiis M.
- Int J Mol Sci. 2020 Jun 27;21(13):E4579. doi: 10.3390/ijms21134579.
- Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer.
- Huang XZ, Jia H, Xiao Q, Li RZ, Wang XS, Yin HY, Zhou X.
- Front Oncol. 2020 Jun 16;10:958. doi: 10.3389/fonc.2020.00958.
- The role of PARP inhibitors in germline BRCA-associated pancreatic ductal adenocarcinoma.
- Moffat GT, O'Reilly EM.
- Clin Adv Hematol Oncol. 2020 Mar;18(3):168-179.